Teva Sues Mylan, Natco Over Copaxone ANDA
By Elaine Meyer ( October 19, 2009, 4:16 PM EDT) -- Teva Pharmaceutical Industries Ltd. has hit Mylan Pharmaceuticals Inc. and Natco Pharma Ltd. with a patent infringement suit over their plans for a generic version of the multiple sclerosis therapy drug Copaxone....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.